Add BrightSurf on Google Email

Karolinska Institutet


Patients with IBD at higher risk of lymphoma

Patients with inflammatory bowel disease (IBD) are at a higher risk of developing lymphoma, particularly those with Crohn's disease. The risk is driven by both the disease activity and treatment, including immunomodulating drugs.

SourceKarolinska Institutet·JournalClinical Gastroenterology and Hepatology·TypeObservational study·DateApr 13, 2023

Children’s lung capacity improved in cleaner air

A new study published in the European Respiratory Journal reports that children's lung capacity has improved in areas with decreased air pollution in Stockholm. The researchers found a 20% lower risk of significantly impaired lung function in participants living in areas with better air quality.

SourceKarolinska Institutet·JournalEuropean Respiratory Journal·TypeObservational study·DateFeb 23, 2023

Heart failure places a great strain on healthcare

A multinational study of over 600,000 heart failure patients found that the disease is relatively fatal, with an average annual death rate of 13%, and results in high healthcare costs. The study also identified new treatment opportunities for heart failure with preserved left ventricular function.

SourceKarolinska Institutet·JournalHeart·TypeObservational study·DateFeb 13, 2023

New immunotherapy holds promise for ovarian cancer

Researchers at Karolinska Institutet have developed a new type of CAR T-cell therapy that effectively attacks and destroys ovarian cancer cells, significantly prolonging the lives of mice with the disease. The treatment has shown promising results in reducing tumor size and curing several mice.

SourceKarolinska Institutet·JournalJournal for ImmunoTherapy of Cancer·TypeRandomized controlled/clinical trial·DateFeb 6, 2023

Poor coparenting linked to depression in dads

A new study by researchers at Karolinska Institutet in Sweden found that poor coparenting relationships among fathers are linked to depression. The study suggests that screening fathers for their coparenting status during infancy and toddlerhood could help prevent mental illness in both parents and children.

SourceKarolinska Institutet·JournalJournal of Affective Disorders·DateJan 24, 2023

Cellular messengers improve cancer therapy

Extracellular vesicles from immune cells have been shown to activate the immune system in mice with skin cancer, rendering them sensitive to checkpoint inhibitor therapy. The treatment improved survival rates when used in combination with checkpoint inhibitors.

SourceKarolinska Institutet·JournalCancer Immunology Research·TypeExperimental study·DateDec 22, 2022

Patients with treatment resistant depression at higher risk of death

A new study published in JAMA Psychiatry finds that patients with treatment-resistant depression have a 23% higher risk of death, as well as significantly more outpatient care and hospitalization days. The researchers emphasize the importance of identifying patients at risk of developing treatment-resistant depression to improve their ...

SourceKarolinska Institutet·JournalJAMA Psychiatry·TypeObservational study·DateDec 14, 2022

Internet treatment for anger works

A new study from Karolinska Institutet shows that internet-based therapy can help people with anger and aggression, with a combination of mindful emotion awareness and cognitive reappraisal being the most effective strategy. Four-week treatments resulted in decreased self-reported anger and aggressiveness.

SourceKarolinska Institutet·JournalJournal of Consulting and Clinical Psychology·TypeRandomized controlled/clinical trial·DateDec 12, 2022

Reduced use of child sexual abuse material after online CBT

Researchers at Karolinska Institutet found that internet-delivered anonymous cognitive behavioural therapy (CBT) significantly reduced the viewing of child sexual abuse material. The study, published in Internet Interventions, shows promise for a feasible and effective treatment approach.

SourceKarolinska Institutet·JournalInternet Interventions·TypeRandomized controlled/clinical trial·DateNov 30, 2022

Study sheds new light on the link between oral bacteria and diseases

Researchers at Karolinska Institutet have identified the most common bacteria found in severe oral infections, shedding new light on the association between oral health and systemic diseases. The study found that certain bacterial infections can spread to other parts of the body, highlighting the importance of understanding the role of...

SourceKarolinska Institutet·JournalMicrobiology Spectrum·TypeObservational study·DateNov 24, 2022

ADHD medication for amphetamine addiction linked to reduced risk of hospitalization and death

A large registry-based study found lisdexamfetamine to be associated with the lowest risk of hospitalisation and death in people with amphetamine addiction. The medication showed a significant reduction in hospitalisation due to substance use disorder and any cause or death, while benzodiazepine and antidepressant use were linked to po...

SourceKarolinska Institutet·JournalJAMA Psychiatry·DateNov 16, 2022

Autistic women have increased risk of mental illness

Researchers found that autistic women are more vulnerable to psychiatric conditions and hospitalization than men, with a higher risk of depression, anxiety disorders, and self-harm. The study suggests that healthcare needs to be expanded for young adults, especially autistic women, to detect mental illness in time.

SourceKarolinska Institutet·JournalJAMA Psychiatry·TypeObservational study·DateOct 26, 2022

New study explains link between diabetes and UTIs

Research at Karolinska Institutet shows that people with diabetes have lower levels of psoriasin, a key peptide that weakens the bladder's protective barrier function. This increases the risk of urinary tract infections. Oestrogen therapy may help regulate the immune response to UTIs in patients with diabetes.

SourceKarolinska Institutet·JournalNature Communications·TypeExperimental study·DateSep 20, 2022

Rheumatoid arthritis drug effective against myasthenia

A randomized clinical trial found that rituximab significantly improved disease control in patients with new-onset myasthenia gravis, reducing the need for cortisone treatments and hospitalizations. The study's results offer hope for a more effective treatment strategy, but larger studies are needed to assess long-term effects.

SourceKarolinska Institutet·JournalJAMA Neurology·TypeRandomized controlled/clinical trial·DateSep 19, 2022